Updated: Botox off the Block: Friday FDA FuckUps & Other Fun Around the Industry
UPDATED November 17, 2014: Actavis agrees to buy Botox-maker Allergan for $66 billion (middle of page). November 14, 2014 Drug Companies Don't Want You To See These Allegations Bloomberg Federal Judge unseals Chicago case much to the dismay of a few of the companies named in the suit....